Granahan Investment Management - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 22 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q1 2021$22,000
-89.6%
10,064
-88.3%
0.00%
-100.0%
Q4 2020$212,000
-37.6%
85,654
-25.4%
0.01%
-58.3%
Q2 2020$340,000
-16.9%
114,829
-25.8%
0.01%
-45.5%
Q1 2020$409,000
-47.6%
154,658
-1.5%
0.02%
-38.9%
Q4 2019$780,000
-7.1%
156,944
+11.3%
0.04%
-21.7%
Q3 2019$840,000
-6.0%
141,012
+1.8%
0.05%
+4.5%
Q2 2019$894,000
-8.5%
138,541
-4.2%
0.04%
-15.4%
Q1 2019$977,000
+64.5%
144,583
-0.9%
0.05%
+23.8%
Q4 2018$594,000145,8440.04%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q3 2019
NameSharesValueWeighting ↓
GARDNER LEWIS ASSET MANAGEMENT L P 1,249,778$2,750,0000.55%
Beryl Capital Management LLC 1,131,772$2,490,0000.26%
DELTEC ASSET MANAGEMENT LLC 155,614$342,0000.08%
Knott David M Jr 41,700$92,0000.04%
TPG GP A, LLC 1,020,748$2,246,0000.04%
GABELLI & Co INVESTMENT ADVISERS, INC. 40,900$90,0000.01%
Ergoteles LLC 135,323$298,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,600$292,0000.01%
Virtu Financial LLC 20,027$44,0000.00%
GABELLI FUNDS LLC 59,100$130,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders